A method to assess the risk of fetal Down's syndrome is not patent-eligible subject matter, the U.S. Court of Appeals for the Federal Circuit has ruled, relying on recent high-profile cases about medical diagnostic patents.
Diagnostic Test for Down Syndrome Not Patent-Eligible
The National Law Journal
November 27, 2012
This article requires premium access
This article requires premium access to The Legal Intelligencer. Please sign in or subscribe to read the full text.